Results 271 to 280 of about 95,583 (387)
Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users.
Tallarico RT+8 more
europepmc +1 more source
Time to Treatment Intensification with Glucagon-Like Peptide-1 Receptor Agonists Versus Comparators in People with Type 2 Diabetes Treated with Metformin. [PDF]
Ostrominski JW+5 more
europepmc +1 more source
Effects of baseline mitral regurgitation in the CABANA trial: randomization to catheter ablation versus drug therapy in patients with atrial fibrillation. AF, atrial fibrillation; CCS, Canadian Cardiovascular Society; MR, mitral regurgitation; NYHA, New York Heart Association; OR, odds ratio.
Sebastiaan Dhont+8 more
wiley +1 more source
Effects of sodium/glucose cotransporter 2 inhibitors on the coagulation profile in patients with coronary-artery disease and type 2 diabetes mellitus: a retrospective cohort study. [PDF]
Qin X, Song G.
europepmc +1 more source
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Pan-ai Song+3 more
semanticscholar +1 more source
Effect of finerenone on a hierarchical endpoint. CI, confidence interval; CV, cardiovascular; EF, ejection fraction; HF, heart failure. ABSTRACT Aims FINEARTS‐HF demonstrated the efficacy of finerenone in reducing total worsening heart failure (HF) events (first and recurrent) and cardiovascular death, compared to placebo, in patients with HF and ...
Toru Kondo+23 more
wiley +1 more source
Severe Impairment of Salivation in Na+/K+/2Cl− Cotransporter (NKCC1)-deficient Mice
Richard L. Evans+9 more
openalex +1 more source
An integrated approach including late gadolinium enhancement data and genetics to predict left ventricular reverse remodelling in patients with dilated and non‐dilated left ventricular cardiomyopathy. DSP, desmoplakin; FLNC, filamin C; LMNA, lamin A/C; LVRR, left ventricular reverse remodelling; LGE, late gadolinium enhancement; MVA, major ventricular ...
Martina Setti+21 more
wiley +1 more source